| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8233352 | International Journal of Radiation Oncology*Biology*Physics | 2010 | 6 Pages |
Abstract
In men with localized but high-risk prostate cancer treated with external beam radiotherapy and brachytherapy, short-course AST with an LHRH agonist plus an antiandrogen is associated with a decreased risk of PCSM when compared with monotherapy with an LHRH agonist.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Akash M.D., Ph.D., Ming-Hui Ph.D., Brian J. M.D., Michelle H. B.S., Daniel M.D., Sharon M.P.H., Michael M.D., Rudi B.S., Anthony V. M.D., Ph.D.,